Short answer
AVANOS MEDICAL, INC. (AVNS) filed an 8-K current report with the SEC on March 12, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). CEO David Pacitti's annual LTI grant target raised 10% from $5,000,000 to $5,500,000, effective 2026.
AVANOS MEDICAL, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- CEO David Pacitti's annual LTI grant target raised 10% from $5,000,000 to $5,500,000, effective 2026
- Increase signals Board confidence in Pacitti's leadership; adds $500K annual equity cost to compensation expense
- Grant issued under existing 2021 Long Term Incentive Plan: no new shareholder dilution authorization required
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other AVANOS MEDICAL, INC. 8-K filings
Get the next AVNS 8-K as it lands
Follow AVNS for push alerts, or ask the research agent what this filing means.